Marcus benefits from premiumization strategies, outperforming industry averages in both box office and hotel RevPAR. Read why I reiterate a Buy for MCS stock.
Scott Feschuk is a columnist for Maclean's and Sportsnet magazines. He writes speeches for business leaders and politicians of varied political stripes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results